# Minimal Effective Concentration (EC90) of Ropivacaine

> **NCT03688269** · PHASE3 · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 146 (actual)

## Conditions studied

- Anesthesia, Conduction
- Ropivacaine
- Dexamethasone
- Axillary Brachial Plexus Block

## Interventions

- **DRUG:** Intravenous dexamethasone
- **DRUG:** Intravenous saline
- **DRUG:** Perineural ropivacaine

## Key facts

- **NCT ID:** NCT03688269
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-05
- **Primary completion:** 2019-11-04
- **Final completion:** 2020-05-04
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2020-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03688269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03688269, "Minimal Effective Concentration (EC90) of Ropivacaine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03688269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*